Stefanie Bailey, PhD, on the Role of Interferon-γ in CAR T-Cell Therapy

Induction Therapy for MCL

Managing Toxicities of Ropeginterferon Alpha-2b in Patients With PV

2020 Update on MPNs: What Is the Risk Adapted Management in PV? Is Ropeginterferon Alfa-2b Effective in Inducing CHR? Can We Achieve Both HCT Control and Spleen Response With Ruxolitinib?

Comparing Hydroxyurea and Pegylated Interferon-Alpha-2a in PV and ET